CJC-1295 No DAC — 10 mg

CJC-1295 No DAC 10 mg is an investigational, short-acting growth-hormone-releasing hormone (GHRH) analog studied for its ability to influence the body’s natural growth hormone signaling pathways. Unlike long-acting GHRH analogs, the No DAC form is characterized by a shorter duration of activity and is primarily investigated for its relationship with pulsatile growth hormone release.

Research involving CJC-1295 No DAC focuses on its potential to stimulate endogenous growth hormone secretion and increase downstream insulin-like growth factor-1 (IGF-1) signaling. This makes the peptide of interest in laboratory studies examining growth hormone physiology, endocrine signaling, and related metabolic pathways.

Research Areas

• Growth Hormone Release: Investigation of endogenous growth hormone secretion and pulsatile release patterns.
• GHRH Signaling: Study of GHRH receptor activity and its role in regulating growth hormone pathways.
• IGF-1 Signaling: Research into downstream IGF-1 activity associated with growth hormone stimulation.
• Endocrine Research: Exploration of interactions within the growth hormone and IGF-1 axis.
• Short-Acting GHRH Activity: Investigation of the pharmacological characteristics and signaling profile associated with the No DAC form.

Explore our complete collection of research peptides and available COA documentation

FOR RESEARCH USE ONLY.